جست‌وجوی استاد و پژوهشگر

• Apoptosis
• Biochemistry
• Breast Neoplasms
• +۵ مورد دیگر

Professor Faye Rogers serves as Professor of Therapeutic Radiology at Yale University School of Medicine, holding multiple leadership positions including Associate Cancer Center Director for YCC Collaborative Excellence, Vice Chair for Collaborative Excellence in Therapeutic Radiology, Associate Director of the Yale MD-PhD Program, and Director of the Yale BioMed Amgen Scholars Program. Her work bridges radiation oncology, DNA repair mechanisms, and cancer therapeutics within Yale's comprehensive cancer research ecosystem. PhD from University of Maryland at Baltimore (1998) Postdoctoral Fellow at Yale School of Medicine Dr. Rogers' research focuses on the intersection of DNA repair mechanisms and cancer therapeutics, with particular expertise in triplex DNA structures, genomic instability, and targeted cancer therapies. Her work explores how DNA damage responses can be leveraged for therapeutic benefit, especially in breast neoplasms and other malignancies. Through her leadership in the DNA Damage and Genome Integrity program, she investigates novel approaches to disrupt cancer cell survival mechanisms while sparing healthy tissue. Her research has significant implications for radiation oncology, particularly in developing more precise and effective radiation-based treatments. Analysis of Dr. Rogers' publication record reveals a consistent trajectory in DNA repair mechanisms and cancer therapeutics, with increasing focus on translational applications. Her work demonstrates expertise in triplex DNA structures, RAD51 inhibition, and synthetic lethality approaches. Recent publications show a shift toward more clinically applicable research, particularly in targeting DNA repair pathways in specific cancer subtypes like IDH1-mutant cancers and PTEN-deficient glioblastomas. Her collaborative work with Peter Glazer and others demonstrates strong interdisciplinary connections between radiation oncology, molecular biology, and drug development. Leadership in Diversity, Equity & Inclusion Award (Yale School of Medicine, 2022) Translational Science Research Prize (Yale Cancer Center, 2022) Kingsley Fellowship in Medical Research Carl Storm Underrepresented Minority Fellowship NCI Research Supplement to Promote Diversity in Health-Related Research As Associate Director of the Yale MD-PhD Program and Director of the Yale BioMed Amgen Scholars Program, Dr. Rogers plays a pivotal role in mentoring the next generation of physician-scientists and supporting underrepresented minorities in biomedical research. Her leadership in collaborative excellence initiatives demonstrates commitment to fostering interdisciplinary research teams across Yale's scientific ecosystem. Through the YCC Collaborative Excellence program, she has secured significant funding for innovative cancer research that bridges basic science and clinical applications, particularly in the areas of DNA repair targeting and radiation oncology. Dr. Rogers leads research within Yale's Therapeutic Radiology department, with strong connections to the Radiobiology program and the Yale Cancer Center. Her work is integrated with the Program in Translational Biomedicine and the Yale Combined Program in the Biological and Biomedical Sciences. Through the BioMed Amgen Scholars Program, she provides critical research opportunities for undergraduate students, particularly those from underrepresented backgrounds, fostering talent in DNA repair research and cancer therapeutics.

Shayesteh Jahanfarمشاهده پروفایل

استاد

• Reproductive Health
• Maternal-Child Health
• Global Health
• +۶ مورد دیگر

Shayesteh Jahanfar is a Professor in the Department of Public Health and Community Medicine at Tufts University School of Medicine, with a secondary appointment in Community Health at the Tufts School of Arts and Sciences. As a reproductive epidemiologist with expertise in public health and biostatistics, she directs the Cochrane Affiliate at Tufts and co-directs the Pregnancy and Childbirth US Satellite with Cochrane. Her global research spans reproductive health, maternal-child health, and genetic versus environmental studies across Australia, Malaysia, Canada, and the USA. Education: Doctor of Philosophy, University of British Columbia, Vancouver, Canada (2016) Doctor of Philosophy, University of New South Wales, Sydney, Australia (1995) Master of Science in Community Health, Universiti Putra Malaysia, Seri Kembangan, Malaysia (2009) Postdoc Epidemiology and Public Health, Universiti Putra Malaysia, Seri Kembangan, Malaysia (2008) Dr. Jahanfar's research program focuses on reproductive health, maternal-child health, global health, HIV/AIDS, opioid use, and twin studies. She leads WHO-funded projects related to reasons for Cesarean sections, family planning, and assisted vaginal birth, and collaborates with WHO's Department of Sexual and Reproductive Health and Research. Her work with twin studies spans multiple international settings, examining genetic versus environmental influences on health outcomes. She actively develops training materials for Cochrane trainers and promotes evidence-based healthcare practices globally. Her recent publications (2025) demonstrate a strong focus on women's health issues, particularly reproductive health, maternal outcomes, and interventions during pregnancy and childbirth. Her research combines epidemiological methods with clinical trials and systematic reviews, often with a global health perspective. She frequently collaborates on research in Iran and other international settings, addressing both clinical and social determinants of health. Her work spans from molecular diagnostics in cancer to behavioral interventions in maternal health, reflecting her interdisciplinary approach to public health research. Scientific Awards: Equity & Inclusion Fellow (2023) Most Stimulating Paper (2019) President and Provost's Research Award Nomination (2019) With over 35 years of teaching experience, Dr. Jahanfar has trained more than 800 clinicians and scientists through over 80 Cochrane workshops worldwide. Her grant portfolio includes multiple WHO-funded projects on family planning, Cesarean sections, and assisted vaginal birth. Under her leadership, Tufts University established a memorandum of understanding with the University of Malaya, facilitating student research projects in Malaysia during Summers 2022-2024. She actively seeks students and researchers to collaborate on Cochrane's work, twin studies, and reproductive health research projects. Dr. Jahanfar directs the Cochrane Affiliate at Tufts and co-directs the Pregnancy and Childbirth US Satellite. She collaborates with WHO's Maternal and Perinatal Health department, Department of Sexual and Reproductive Health and Research, and serves as a consultant for WHO and EMRO. Her global health research initiatives span Australia, Malaysia, Egypt, Iran, Europe, and the Middle East, reflecting her commitment to advancing global health education and research through international partnerships.

Erica C Jansenمشاهده پروفایل

استادیار

• Sleep
• Nutrition
• Dietary Patterns
• +۵ مورد دیگر

Dr. Erica C Jansen serves as Assistant Professor in the Department of Nutritional Sciences at the University of Michigan School of Public Health and holds a secondary appointment as Research Assistant Professor in Neurology. Her work bridges nutritional epidemiology and sleep science, focusing on lifespan health impacts with specialized attention to adolescent and women's health outcomes. Her educational foundation includes: PhD in Epidemiology, University of Michigan School of Public Health (2016) MPH in Epidemiology, University of Michigan School of Public Health (2014) BS in Biology, Hope College (2012) Dr. Jansen's research program centers on bidirectional sleep-nutrition interactions and their cardiometabolic consequences. Key pillars include: Early-life nutritional environments and puberty timing Objective sleep metrics (duration, timing, quality) and cardiometabolic risk Epigenetic mechanisms in sleep-diet-health pathways Toxicant exposures through dietary sources Life-stage specific analyses (adolescence, pregnancy, midlife) She primarily leverages the ELEMENT cohort—a 25+ year Mexican birth cohort—and complementary datasets like NHANES and BioCycle. Analysis of her 2021-2025 publications reveals consistent methodological approaches: Integration of actigraphy for objective sleep measurement Dietary pattern analysis over single-nutrient approaches Epigenome-wide assessments of circadian genes Focus on health disparities through socioeconomic and environmental lenses Strong emphasis on Mexican and US minority populations Her work increasingly incorporates machine learning for sleep data analysis and examines policy-relevant questions like food expenditure patterns. Current funding includes: NHLBI K01 grant (K01HL151673) examining sleep-cardiometabolic links in adolescents Gilmore Grant and MNORC Pilot funding for circadian gene methylation studies in pregnancy and midlife Dr. Jansen actively mentors through: NUTR703: Guiding MS students in thesis development and scientific communication PUBHLTH417: Teaching undergraduates to investigate sleep-nutrition interplay through hands-on research Her collaborative network spans Michigan Medicine, environmental health scientists, and international cohorts studying developmental origins of health. Her research team operates within the ELEMENT study infrastructure and partners with clinical departments to translate findings into public health interventions targeting sleep hygiene and dietary patterns for cardiometabolic risk reduction.

• Molecular Imaging
• Radiopharmaceuticals
• Cancer Targeting
• +۷ مورد دیگر

Mary Rusckowski, PhD, is an Associate Professor in the Department of Radiology at UMass Chan Medical School and holds an additional appointment at the T.H. Chan School of Medicine. Her research focuses on developing novel radiopharmaceuticals and molecular imaging agents for cancer, infection, and other diseases. Education: BA in Biology, Albertus Magnus College PhD in Biochemistry, Rutgers University Research Interests: Rusckowski's work integrates chemistry, biology, and imaging to create targeted diagnostic and therapeutic agents. Her major areas include: Design of radiolabeled antisense oligonucleotides for infection and cancer imaging Pretargeting strategies using morpholino oligomers and complementary chemistry Nanoparticle-based delivery systems for theranostics Development of novel chelators and radiolabeling techniques for technetium, indium, and lutetium isotopes Publication Trends: Her extensive publication record (1997–2024) reveals a consistent focus on advancing nuclear medicine and molecular imaging. Recent works emphasize infection-specific imaging agents, VEGF-targeted radiotherapy, and precision delivery systems for dermatological and neurological applications. Labs and Collaborations: While specific lab names are not provided, her co-authorship network includes prominent researchers such as Dale Greiner, John Harris, and Robert Brown, indicating active collaboration within UMass Chan and beyond.

Roberta Bivinsمشاهده پروفایل

استاد

• Medical History
• Migration and Medicine
• Public Health Policy
• +۴ مورد دیگر

Professor Roberta Bivins is a leading historian of medicine and health at the University of Warwick , affiliated with the Department of History within the Faculty of Arts . Her research focuses on the intersections of migration, medicine, and public health policy, particularly the medicalization of borders and systemic health inequities. She has led major projects such as the Wellcome Trust-funded study on the cultural significance of the NHS, resulting in a 'People's Encyclopaedia of the NHS' and a virtual museum. Her academic career includes roles as a Wellcome Lecturer at Cardiff University and Assistant Professor at the University of Houston. She holds a PhD from MIT (1997) and a BA from Columbia University (1991). Her teaching spans undergraduate and postgraduate modules, including 'Surveillance States: Biometrics from the Border to the Bathroom' and 'Foreign Bodies, Contagious Communities: Migration in the Modern World'. Research interests include genetics, household health practices, and the cultural history of healthcare systems. She has supervised PhDs on topics ranging from urban public hospitals to population studies in India. Awards include Wellcome Trust fellowships, and she currently leads the Centre for the History of Medicine and serves on Warwick's Health Steering Committee. Education: PhD, Massachusetts Institute of Technology, 1997 BA, Columbia College, Columbia University, 1991 Major Grants: Wellcome Trust-funded project on the NHS (2015-2020) Labs/Teams: Director, Centre for the History of Medicine (2022–2025) Leadership Team, Health Spotlight (2024–present)

Lance A. Johnsonمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Apolipoprotein E (APOE)
• Cerebral Metabolism
• +۱۰ مورد دیگر

Lance A. Johnson, PhD, is an Associate Professor in the Department of Physiology at the University of Kentucky College of Medicine. He is also affiliated with the Sanders-Brown Center on Aging and the Nutritional Sciences Graduate Faculty. His research focuses on the role of Apolipoprotein E (APOE) in cerebral metabolism and neurodegeneration, particularly in Alzheimer’s disease. Department: Department of Physiology School: College of Medicine Institution: University of Kentucky Lab: Johnson Lab, Healthy Kentucky Research Building Dr. Johnson’s research investigates how APOE isoforms, especially APOE4, influence brain metabolism through glial contributions. His lab uses transcriptomic and metabolomic techniques across models—from cells to mice to humans—to identify early metabolic dysregulations. Key projects include studying the pentose phosphate pathway, lipid droplet dynamics, and developing the novel APOE 'switch mouse' model to test therapeutic replacement of APOE4 with neuroprotective APOE2. His recent publications span neuroscience, oncology, metabolism, and clinical research. Notably, he co-authored a 2024 Science perspective on APOE and IDO1 in Alzheimer’s, and contributed to studies in Nature on cancer metastasis and Nature Nanotechnology on gene-editing nanoparticles. These reflect a broad interdisciplinary impact, though his core focus remains on brain aging and metabolic resilience. Scientific contributions include: Development of the APOE 'switch mouse' model Creation of the APOE Immunometabolism Database Leadership in multi-lab collaborations (e.g., with Morganti and Sun labs) Dr. Johnson mentors a diverse team of PhD candidates, MD/PhD students, and research analysts. He serves as Director of Graduate Studies in Physiology, indicating active academic leadership. He has not received any explicitly mentioned awards in the provided text. His lab recently relocated to expanded space in the Healthy Kentucky Research Building, supporting ongoing growth. No part-time status or retirement indications are present.

Simon Boultonمشاهده پروفایل

استاد

• DNA Damage Response
• DNA Repair
• Genome Integrity & Repair
• +۷ مورد دیگر

Simon Boulton is a distinguished molecular biologist and cancer researcher serving as a Senior Group Leader at the Francis Crick Institute and holding an honorary Professorship at University College London. He also serves as Senior Vice President of Science Strategy at Artios Pharma Ltd, which he helped establish in 2016, where he additionally chairs the Scientific Advisory Board and serves on the Executive Board. His educational background includes: Molecular Biology studies at the University of Edinburgh PhD at the University of Cambridge with Professor Steve Jackson (Gurdon Institute) EMBO and HFSP funded postdoctoral fellowships at Harvard Medical School with Prof. Nick Dyson (MGH Cancer Centre) and Prof. Marc Vidal (Dana Farber Cancer Institute) Boulton's research focuses on understanding DNA damage response mechanisms, particularly DNA double-strand break repair in both mitotic and meiotic cells. His laboratory employs the complementary experimental strengths of C. elegans and mouse genetics, combined with cell biology and biochemistry approaches. Over his career, his lab has discovered novel DNA repair genes and provided crucial molecular insights into human diseases, especially cancer. His work bridges fundamental biological processes with potential therapeutic applications in oncology. Analysis of his recent publications reveals a consistent focus on genome integrity mechanisms, with particular emphasis on DNA repair pathways, telomere biology, replication stress responses, and the development of novel assays to study these processes. His research increasingly intersects with cancer therapeutics, particularly through his work with Artios Pharma on DNA Damage Response (DDR) target pipelines. His significant scientific contributions have been recognized with numerous prestigious awards: Member of EMBO Fellowship of the Academy of Medical Sciences Colworth Medal European Association for Cancer Research (EACR) Young Investigator Award Eppendorf/Nature Award for Young European Investigators Royal Society Wolfson Research Merit award EMBO Gold Medal Paul Marks Prize for Cancer Research Royal Society Francis Crick Prize lecture Mendel Lecture Boulton has secured substantial research funding throughout his career, including EMBO and HFSP postdoctoral fellowships, and currently leads a well-funded research group at the Crick Institute. His dual role in academia and industry through Artios Pharma demonstrates a successful translation of basic research into therapeutic development, with the company building an innovative DNA Damage Response (DDR) target pipeline aimed at transforming cancer therapy. His laboratory at the Francis Crick Institute maintains strong collaborative networks across multiple disciplines, utilizing advanced facilities including proteomics, genomics, bioinformatics, and microscopy resources. The lab's work spans from fundamental DNA repair mechanisms to potential clinical applications, with a particular focus on how failures in DNA repair contribute to cancer and other diseases.

Chloe E. Atreyaمشاهده پروفایل

استاد

• Gastrointestinal Cancer
• Colorectal Cancer
• Tumor Genetics
• +۵ مورد دیگر

Dr. Chloe E. Atreya is a Professor of Medical Oncology at the University of California San Francisco (UCSF) School of Medicine, specializing in gastrointestinal and colorectal cancers at the UCSF Helen Diller Comprehensive Cancer Center. She co-directs the Integrative Oncology Program and Research Hub, focusing on tumor genetics, personalized therapy, and gut microbiome interactions to improve patient outcomes. Her research integrates clinical trials with molecular analysis to overcome treatment resistance. Dr. Atreya's educational background includes: BA in Molecular Biology with Visual Art Certificate from Princeton University (1998) PhD in Pharmacology and MD from Yale University (2004, 2005) Internal Medicine residency at University of Washington (2008) Medical Oncology fellowship and Advanced Clinical Research Training at UCSF (2010, 2014) Clinical Fellowship in Integrative Medicine (2018-2019) Her research spans tumor genetics, gut microbiome interactions, and integrative oncology approaches. Recent publications reveal strong focus on microbiome-mediated drug metabolism, precision medicine strategies for KRAS/BRAF-mutant cancers, and patient-centered interventions for cancer survivors. She leads multiple NIH-funded projects examining resistance mechanisms and nutritional interventions. Dr. Atreya has received significant recognition including: ASCO Young Investigator Award (2011) Multiple UCSF research awards (2012-2017) Sandler Program Breakthrough Award (2022) ASCO-Integrative Oncology Clinical Guidelines leadership As Principal Investigator on multiple NIH grants including R01CA229447 and R37CA266549, she directs translational research programs examining kinome-guided targeting and KRAS inhibition resistance. Her work bridges basic science with clinical applications through the Integrative Oncology Research Hub, developing evidence-based complementary approaches for symptom management and quality of life improvement.

• Inorganic Chemistry
• Coordination Chemistry
• Bioinorganic Chemistry
• +۴ مورد دیگر

Ioannis Plakatouras is Professor of Inorganic Chemistry in the Department of Chemistry at the University of Ioannina, Greece, where he has held an uninterrupted academic career since 1997, progressing from Assistant Professor to full Professor in 2011. He leads the Laboratory of Magnetochemistry, has co-supervised numerous MSc and PhD students, and has participated in several national and European research programmes. Education B.Sc. in Chemistry, Department of Chemistry, University of Ioannina, 1988 – Grade: Very Good Ph.D. in Inorganic Chemistry, Department of Chemistry, University of Ioannina, 1992 – Grade: Excellent (supervisor: Assist. Prof. Spiros P. Perlepes) Research interests His research focuses on the synthesis and characterization of coordination compounds , spanning from classic Werner-type complexes to extended coordination polymers and metal–organic frameworks. A major theme is bioinorganic chemistry , investigating the interaction of essential (Cu²⁺, Zn²⁺) and toxic (Ni²⁺) metal ions with peptide fragments derived from histones and enzymes. Complementary work targets the design of Gd(III) and lanthanide complexes as MRI contrast agents and the study of magnetochemical properties of transition-metal and lanthanide systems. Research output & trends With over 65 peer-reviewed publications, his work shows a clear evolution from fundamental synthetic and structural studies of mononuclear complexes (late 1980s–1990s) to the construction of multi-dimensional coordination polymers and supramolecular architectures (2000s–2010s). Recent articles increasingly integrate computational chemistry and explore functional materials with potential biomedical applications, reflecting a strategic shift towards translational inorganic chemistry. Awards & fellowships NFWO Post-doctoral Fellowship, Belgium, July 1989 National Hellenic Research Foundation Fellowship, Sep 1989 – Aug 1990 SERC Post-doctoral Fellowship, United Kingdom, Mar 1993 – Feb 1996 Advising & grants He has directed 10 MSc theses and 4 PhD theses, and served on 10 additional PhD supervisory committees. Funding has been secured through HERACLITUS (2003–2007) , COST Action D18 (2000–2006) , EPEAEK & EPEAEK II “Bioinorganic Chemistry” , and regional “PEP” Epirus programmes. Laboratories & teams Since 1999 he has been Scientific Coordinator of the Laboratory of Magnetochemistry , University of Ioannina, managing instrumentation for magnetic susceptibility and EPR measurements. He is also a member of the Scientific Committee of the Laboratory of X-ray Crystallography, facilitating single-crystal and powder diffraction studies.

Julie A. Akeمشاهده پروفایل

پزشک-پژوهشگر

• HIV Research and Vaccinology
• Infectious Diseases and Global Health
• Clinical Trials and Cohort Studies
• +۴ مورد دیگر

Dr. Julie A. Ake is a physician scientist at the Walter Reed Army Institute of Research (WRAIR), where she works in the Infectious Disease Clinical Research Program (IDCRP) focusing on HIV & Tuberculosis Epidemiology. With extensive clinical and research expertise, she contributes to military medicine and global infectious disease initiatives through her dual background in medicine and public health. Her educational background includes: Doctor of Medicine (MD) from University of Washington - School of Medicine (1999-2003) MSc in Health Policy Planning and Financing from London School of Hygiene and Tropical Medicine, University of London (1998-1999) A.B. in Economics and Public Policy from Stanford University (1994-1998) Dr. Ake's research program integrates clinical medicine with epidemiological investigation, focusing on HIV vaccine development and implementation in resource-limited settings. Her work in military medicine addresses infectious disease threats to deployed personnel, while her global health research emphasizes health equity for marginalized populations including sexual and gender minorities. Her expertise spans clinical trial design, cohort study methodology, and pandemic response strategies, with significant contributions during the COVID-19 pandemic examining SARS-CoV-2 in HIV-affected populations. Analysis of her recent publications reveals a strategic research portfolio advancing HIV prevention science through multiple complementary approaches: immunological studies of vaccine responses, computational vaccine design, and implementation research addressing behavioral barriers to prevention. Her work in Nigeria with men who have sex with men and transgender women demonstrates her commitment to addressing health disparities through culturally competent research. Dr. Ake has served as principal investigator on major research initiatives including: HIV Vaccine Research and Development (2020-2022) HIV Vaccine Research and Development - Central Nervous System Studies (2019-2020) The Military HIV Research Program (MHRP) Clinical Trial Unit (2013-2022) Her research network spans multiple continents with particularly strong collaborations in Africa, reflecting her dedication to building research capacity and addressing global health challenges through international partnerships. With 156 research outputs and an h-index of 30, her work has significantly influenced the field of HIV research and prevention.

Alberto Ravagnaniمشاهده پروفایل

دانشیار

• Coding Theory
• Network Communication
• Combinatorics
• +۴ مورد دیگر

Alberto Ravagnani is an Associate Professor in the Department of Mathematics and Computer Science at Eindhoven University of Technology (TU/e), the Netherlands. He specializes in the mathematical foundations of communication theory, with a focus on coding theory, network communication, and combinatorics. His research addresses challenges in error-correcting codes, network coding, quantum error correction, and applications in data storage and cryptography. He holds a PhD from the University of Neuchâtel, Switzerland, and has held academic positions at institutions including University College Dublin, Ireland, and the University of Zurich. His work has been recognized with awards such as the KNAW Early Career Award (2021), Ambizione Research Grant (2019), and the Nexans Prize (2017). Ravagnani’s research spans theoretical and applied domains, including rank-metric codes, network decoding, and combinatorial structures. His recent publications explore eigenvalue bounds for codes, densities in metric spaces, and evasive subspaces. He is actively involved in editorial roles for journals like IEEE Transactions on Information Theory and Designs, Codes and Cryptography. His teaching includes courses on coding theory and combinatorics, and he has mentored multiple PhD students in areas such as DNA storage and quantum error correction. Key grants include a NWO Gravitation Grant (EUR 10M) and an EuroTech PhD Program Grant (EUR 235K).

Vasso Apostolopoulosمشاهده پروفایل

استاد

• Immunology
• Vaccine Development
• Chronic Disease Research
• +۷ مورد دیگر

Vasso Apostolopoulos is a Distinguished Professor and Head of the Healthy Lifespan and Chronic Diseases Program at RMIT University's School of Health and Biomedical Sciences in Melbourne, Australia. She holds leadership roles in immunology research, including Program Director at the Australian Institute for Musculoskeletal Science and former Deputy Vice-Chancellor Research at Victoria University. Her expertise spans immunology, x-ray crystallography, and translational medicine, with a focus on vaccines, drug development, and chronic disease interventions. Education: PhD in Immunology from the University of Melbourne (1995). Prior roles include leadership at institutions like the Burnet Institute and the Austin Research Institute, as well as industry roles as Chief Scientific Officer at 4Gvaccines. She has over 500 peer-reviewed publications, 20 patents, and has mentored ~70 graduate students. Research Interests: Developing vaccines/drugs for cancer, diabetes, Alzheimer’s, and infectious diseases; leveraging AI for healthcare innovation; pandemic preparedness via the ELPanvir consortium. Awards include Young Australian of the Year and recognition by Times magazine as a top diaspora Greek scientist. Collaboration Availability: Open to industry projects, student supervision (Masters/PhD), advisory roles, and media engagements. Active on editorial boards and community initiatives like the Greek Australian Society and Wyndham Committee.

• Cancer Chemoprevention
• Colorectal Cancer
• Clinical Trials
• +۴ مورد دیگر

Professor Karen Brown is Director of the Leicester Cancer Research Centre and joint lead of the Leicester Experimental Cancer Medicine Centre. She co-chairs the UK Therapeutic Cancer Prevention Network and represents this network on the steering group of the Cancer Prevention Europe Consortium. Her research focuses on discovering and translating chemopreventive agents for high-risk populations, leading major trials like COLO-PREVENT investigating resveratrol, aspirin, and metformin in colorectal polyp prevention. Funded by Cancer Research UK, this trial operates across 60 UK sites. Karen holds leadership roles across multiple national/international grant panels, including the Cancer Research UK Prevention and Population Research Committee, and sits on panels for the World Cancer Research Fund International and Breast Cancer Now. Her work bridges preclinical discovery and clinical implementation, emphasizing pharmacodynamic biomarkers and drug metabolism. Key contributions include advancing understanding of metabolic pathways in cancer prevention, BRAF mutation-driven colorectal neoplasia, and diabetes-cancer comorbidity. She advocates for European cancer prevention initiatives through Cancer Prevention Europe and addresses healthcare inequities in screening and treatment access for ethnic minorities and diabetes patients. Karen’s research portfolio spans over 50 peer-reviewed articles, with recent work exploring resveratrol’s microbiome effects and curcumin’s role in colorectal therapy. Professional service includes Vice-Chair roles on grant review panels and former presidency of the UK Environmental Mutagen Society. Her lab develops ex vivo models to assess patient-specific responses to cancer prevention agents and collaborates internationally on guidelines for familial cancer syndromes like FAP and MUTYH-associated polyposis.

• Nanotechnology
• DNA Nanotechnology
• Molecular Engineering
• +۳ مورد دیگر

Longfei Liu is an Associate Research Scientist in the Department of Cell Biology at Yale School of Medicine, Yale University. His research focuses on DNA nanotechnology, molecular engineering, and their applications in materials science and biophysics. Collaborators include prominent researchers such as Chenxiang Lin, Erdem Karatekin, and Frederic Pincet. Key research interests include DNA self-assembly, nanostructuring, and the development of programmable nanodevices. Recent work explores molecular lithography on silicon wafers, DNA-based membrane interactions, and the creation of tunable transmembrane channels using DNA-origami-protein hybrids. Liu has contributed to advancements in DNA binary crystals, lipidosome sorting, and CRISPR-mediated DNA origami processing. Publications emphasize interdisciplinary approaches, combining chemistry, physics, and engineering to design functional nanomaterials. His work bridges fundamental molecular mechanisms with applied technologies in drug delivery, diagnostics, and biomaterials. No specific awards or grants are listed in the provided text.

FERIDUN BÜLBÜLمشاهده پروفایل

استاد

• Psychiatry
• Mental Health
• Oxidative Stress
• +۵ مورد دیگر

Professor Feridun Bülbül currently holds the position of Professor at Çukurova University Faculty of Medicine, Department of Internal Medical Sciences . He has previously served as Associate Professor at Gaziantep University Faculty of Medicine, Department of Psychiatry. His academic career spans psychiatry, mental health, and the intersection of oxidative stress with psychiatric disorders. Key areas of focus include schizophrenia, bipolar disorder, electroconvulsive therapy (ECT), and psychopharmacology . Over the years, he has led or contributed to numerous studies on oxidative stress markers, sarcopenia, biological rhythms, and ECT applications in diverse populations, including pregnant patients and refugees. His notable scientific award includes the Anadolu Tıbbi Onkoloji Derneği Çalışma Ödülü in 2015. He has mentored several students, such as Mehmet Fatih Taştan , Bülent Bayar , and Osman Hasan Tahsin Kılıç , guiding their research on topics like peroxiredoxin-1, urotensin-2, and oxidative DNA damage .